Igg Antibody Testing H1N1

Lab Reagents

Igg Antibody Laboratories manufactures the igg antibody testing h1n1 reagents distributed by Genprice. The Igg Antibody Testing H1N1 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Antibody Group: Testing H1N1

Testing H1N1 information

Influenza A H1N1 Antibody

abx023045-100ug 100 ug
EUR 843

Influenza A H1N1 Antibody

abx023046-100ug 100 ug
EUR 801

Influenza-A H1N1 Antibody

20-abx137508
  • EUR 230.00
  • EUR 1790.00
  • EUR 328.00
  • 10 ug
  • 1 mg
  • 50 ug

Influenza-A H1N1 Antibody

20-abx137503
  • EUR 940.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 15 ug
  • 5 ug

Seasonal H1N1 Hemagglutinin Antibody

24917-100ul 100ul
EUR 390

Swine H1N1 Hemagglutinin Antibody

24918-100ul 100ul
EUR 390

Seasonal H1N1 Hemagglutinin Antibody

24919-100ul 100ul
EUR 390

Swine H1N1 Hemagglutinin Antibody

24920-100ul 100ul
EUR 390

Seasonal H1N1 Hemagglutinin Antibody

24921-100ul 100ul
EUR 390

Swine H1N1 Hemagglutinin Antibody

24922-100ul 100ul
EUR 390

Seasonal H1N1 Neuraminidase Antibody

24924-100ul 100ul
EUR 390

Swine H1N1 Neuraminidase Antibody

24925-100ul 100ul
EUR 390

Influenza A H1N1 antibody

10R-7791 50 ug
EUR 565
Description: Mouse monoclonal Influenza A H1N1 antibody

Influenza A antibody (H1N1)

20-IG23 1 mg
EUR 116
Description: Goat polyclonal Influenza A antibody (H1N1)

Influenza A antibody (H1N1)

20C-CR1233GP 1 ml
EUR 426
Description: Goat polyclonal Influenza A antibody (H1N1)

Seasonal H1N1 Hemagglutinin Antibody

5231-002mg 0.02 mg
EUR 171.82
Description: Seasonal H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Seasonal H1N1 Hemagglutinin Antibody

5231-01mg 0.1 mg
EUR 436.42
Description: Seasonal H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.